Dr. Reddys Laboratories Ltd has reported Q3FY23 financial results for the period ending December 31, 2022.
Financial Results (Q3 FY2023) – QoQ Comparison
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹6848.5 crs | ₹6372.6 crs |  7.47% |
| Net Profit | ₹1243.9 crs | ₹1114.2 crs | 11.64% |
| EPS | ₹74.76 | ₹66.98 | 11.62% |
Financial Results (Q3 FY2023) – YoY Comparison
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹6848.5 crs | ₹5394.1 crs | 26.96% |
| Net Profit | ₹1243.9 crs | ₹709.3 crs | 75.37% |
| EPS | ₹74.76 | ₹42.65 | 75.29% |
217